STTK
Shattuck Labs Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Shattuck Labs Inc is a biotechnology company focused on developing immunotherapies for cancer and other immune-related diseases.
Shattuck Labs Inc
STTK
Shattuck Labs Inc is a biotechnology company focused on developing immunotherapies for cancer and other immune-related diseases.
Price history of Shattuck Labs Inc
Price history of Shattuck Labs Inc
Performance & Momentum
Strategic Analysis
Shattuck Labs Inc • 2026
Shattuck Labs is a development-stage biotechnology company focused on innovative immunotherapies for oncology and autoimmune diseases. Its positioning is based on a differentiated scientific approach in areas with high unmet medical need, with the binary upside typical of clinical-stage research biotechs.
- Exposure to two attractive therapeutic markets, oncology and autoimmunity
- Innovative immunotherapy positioning, which could create value if clinical programs advance
- Strong renewed interest from the market, reflecting favorable trading momentum
- High dependence on clinical and regulatory outcomes, with significant risk of failure
- Historically very volatile profile, typical of a biotech still exposed to dilution and execution risk
Momentum is very strong and signals a marked re-rating phase, likely supported by positive expectations around the company’s pipeline or risk profile. For investors, this improves the tactical appeal of the name, but the investment case remains speculative and should be assessed in light of clinical and financial visibility.
Similar stocks to Shattuck Labs Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
